The impact of chronic TNFα on γδ T cells was reversible, suggesting that therapeutic strategies targeting the inflammatory environment and γδ T cell dysfunction may provide additional treatments for complications associated with obesity, metabolic disease and type 2 diabetes. The gene discussed is TNF; the disease is obesity due to melanocortin 4 receptor deficiency.